IDEAYA Biosciences Stock

IDEAYA Biosciences ROCE 2024

IDEAYA Biosciences ROCE

-0.22

Ticker

IDYA

ISIN

US45166A1025

WKN

A2PJPB

In 2024, IDEAYA Biosciences's return on capital employed (ROCE) was -0.22, a 21.03% increase from the -0.18 ROCE in the previous year.

IDEAYA Biosciences Aktienanalyse

What does IDEAYA Biosciences do?

IDEAYA Biosciences Inc is a biotechnology company focused on the development of cancer therapies. The company was founded in 2015 by Yujiro S. Hata and is headquartered in South San Francisco, California. IDEAYA's business model consists of the discovery and development of precision medicine products based on targeted therapies. Targeted therapies are cancer treatments that aim at the specific characteristics of the tumor and have less harmful effects on normal tissue than traditional chemotherapeutics. IDEAYA specializes in the research and development of cancer drugs in three different areas: precision medicine, synthetic lethality, and resistance mechanisms. The company collaborates closely with leading experts in cancer research to develop innovative therapies. In the field of precision medicine, IDEAYA focuses on the development of products based on genetic alterations that cause specific tumors. These genetic alterations are unique to each type of cancer and each individual, meaning that precision medicine products must be individually tailored to each type of cancer. In the area of synthetic lethality, IDEAYA examines the interactions between cancer cells and their environment. These interactions can involve genetic or proteomic changes that make cancer cells dependent on certain signaling pathways and metabolic processes. IDEAYA develops drugs that exploit these dependencies to block the growth of cancer cells. In the area of resistance mechanisms, IDEAYA investigates the mechanisms that cancer cells develop to become resistant to cancer drugs. This involves the discovery of compounds that can bypass these mechanisms and make the cancer cells sensitive to treatments again. IDEAYA has several products in the pipeline, including Inhibat (IDE196) and polyclonal antibodies. Inhibat (IDE196) is a potent and highly selective BRAF inhibitor used in clinical trials for cancer. Polyclonal antibodies are monoclonal antibodies used in cancer immunotherapy. IDEAYA is a company focused on the development of innovative cancer drugs. The company has a solid foundation in cancer research and works closely with leading experts to develop innovative therapies. The company has several products in the pipeline and is working hard to make a significant contribution in cancer research. IDEAYA Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling IDEAYA Biosciences's Return on Capital Employed (ROCE)

IDEAYA Biosciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing IDEAYA Biosciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

IDEAYA Biosciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in IDEAYA Biosciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about IDEAYA Biosciences stock

What is the ROCE (Return on Capital Employed) of IDEAYA Biosciences this year?

The ROCE of IDEAYA Biosciences is -0.22 undefined this year.

How has the ROCE (Return on Capital Employed) of IDEAYA Biosciences developed compared to the previous year?

The ROCE of IDEAYA Biosciences has increased by 21.03% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of IDEAYA Biosciences?

A high Return on Capital Employed (ROCE) indicates that IDEAYA Biosciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of IDEAYA Biosciences?

A low ROCE (Return on Capital Employed) can indicate that IDEAYA Biosciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from IDEAYA Biosciences impact the company?

An increase in the ROCE of IDEAYA Biosciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of IDEAYA Biosciences affect the company?

A decrease in ROCE of IDEAYA Biosciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of IDEAYA Biosciences?

Some factors that can affect IDEAYA Biosciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of IDEAYA Biosciences so important for investors?

The ROCE of IDEAYA Biosciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can IDEAYA Biosciences take to improve the ROCE?

To improve the ROCE, IDEAYA Biosciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does IDEAYA Biosciences pay?

Over the past 12 months, IDEAYA Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEAYA Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEAYA Biosciences?

The current dividend yield of IDEAYA Biosciences is .

When does IDEAYA Biosciences pay dividends?

IDEAYA Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEAYA Biosciences?

IDEAYA Biosciences paid dividends every year for the past 0 years.

What is the dividend of IDEAYA Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEAYA Biosciences located?

IDEAYA Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEAYA Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEAYA Biosciences from 8/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/2/2024.

When did IDEAYA Biosciences pay the last dividend?

The last dividend was paid out on 8/2/2024.

What was the dividend of IDEAYA Biosciences in the year 2023?

In the year 2023, IDEAYA Biosciences distributed 0 USD as dividends.

In which currency does IDEAYA Biosciences pay out the dividend?

The dividends of IDEAYA Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IDEAYA Biosciences

Our stock analysis for IDEAYA Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IDEAYA Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.